PROBLEM: Illicit use of injected drugs is linked with high rates of HIV infection and fatal overdose, as well as community concerns about public drug use. Supervised injecting facilities have been proposed as a potential solution, but fears have been raised that they might encourage drug use. DESIGN: A before and after study. Participants and setting 871 injecting drug users recruited from the community in Vancouver, Canada. KEY MEASURES FOR IMPROVEMENT: Rates of relapse into injected drug use among former users and of stopping drug use among current users. STRATEGIES FOR CHANGE: Local health authorities established the Vancouver supervised injecting facility to provide injecting drug users with sterile injecting equipment, intervention in the event of overdose, primary health care, and referral to external health and social services. EFFECTS OF CHANGE: Analysis of periods before and after the facility's opening showed no substantial increase in the rate of relapse into injected drug use (17% v 20%) and no substantial decrease in the rate of stopping injected drug use (17% v 15%). LESSONS LEARNT: Recently reported benefits of supervised injecting facilities on drug users' high risk behaviours and on public order do not seem to have been offset by negative community impacts.
PROBLEM: Illicit use of injected drugs is linked with high rates of HIV infection and fatal overdose, as well as community concerns about public drug use. Supervised injecting facilities have been proposed as a potential solution, but fears have been raised that they might encourage drug use. DESIGN: A before and after study. Participants and setting 871 injecting drug users recruited from the community in Vancouver, Canada. KEY MEASURES FOR IMPROVEMENT: Rates of relapse into injected drug use among former users and of stopping drug use among current users. STRATEGIES FOR CHANGE: Local health authorities established the Vancouver supervised injecting facility to provide injecting drug users with sterile injecting equipment, intervention in the event of overdose, primary health care, and referral to external health and social services. EFFECTS OF CHANGE: Analysis of periods before and after the facility's opening showed no substantial increase in the rate of relapse into injected drug use (17% v 20%) and no substantial decrease in the rate of stopping injected drug use (17% v 15%). LESSONS LEARNT: Recently reported benefits of supervised injecting facilities on drug users' high risk behaviours and on public order do not seem to have been offset by negative community impacts.
Authors: Evan Wood; Patricia M Spittal; Will Small; Thomas Kerr; Kathy Li; Robert S Hogg; Mark W Tyndall; Julio S G Montaner; Martin T Schechter Journal: CMAJ Date: 2004-05-11 Impact factor: 8.262
Authors: Evan Wood; Thomas Kerr; Will Small; Kathy Li; David C Marsh; Julio S G Montaner; Mark W Tyndall Journal: CMAJ Date: 2004-09-28 Impact factor: 8.262
Authors: T Kerr; E Wood; E Grafstein; T Ishida; K Shannon; C Lai; J Montaner; M W Tyndall Journal: J Public Health (Oxf) Date: 2004-11-25 Impact factor: 2.341
Authors: M C Doherty; R S Garfein; D Vlahov; B Junge; P J Rathouz; N Galai; J C Anthony; P Beilenson Journal: Am J Epidemiol Date: 1997-04-15 Impact factor: 4.897
Authors: Evan Wood; Thomas Kerr; Julio S Montaner; Steffanie A Strathdee; Alex Wodak; Catherine A Hankins; Martin T Schechter; Mark W Tyndall Journal: Lancet Infect Dis Date: 2004-05 Impact factor: 25.071
Authors: D C Des Jarlais; H Hagan; S R Friedman; P Friedmann; D Goldberg; M Frischer; S Green; K Tunving; B Ljungberg; A Wodak Journal: JAMA Date: 1995-10-18 Impact factor: 56.272
Authors: Kora DeBeck; Tessa Cheng; Julio S Montaner; Chris Beyrer; Richard Elliott; Susan Sherman; Evan Wood; Stefan Baral Journal: Lancet HIV Date: 2017-05-14 Impact factor: 12.767
Authors: Sarah Ickowicz; Evan Wood; Huiru Dong; Paul Nguyen; Will Small; Thomas Kerr; Julio S G Montaner; M-J Milloy Journal: Drug Alcohol Depend Date: 2017-08-10 Impact factor: 4.492